Peter A Thompson Insider Trading $SBTX Silverback Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Peter A Thompson.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Peter A Thompson. Peter A Thompson is Director in RESPONSE BIOMEDICAL CORP ($RPBIF) and Director in ProNAi Therapeutics Inc ($DNAI) and President and CEO in Trubion Pharmaceuticals, Inc ($TRBN) and President, CEO & Treasurer in Trubion Pharmaceuticals, Inc ($TRBN) and Director in Synthorx, Inc. ($THOR) and Director in Adaptimmune Therapeutics PLC ($ADAP) and Director in ALPINE IMMUNE SCIENCES, INC. ($NVLS) and Director in Corvus Pharmaceuticals, Inc. ($CRVS) and Director in Decibel Therapeutics, Inc. ($DBTX) and Director in Silverback Therapeutics, Inc. ($SBTX) and Director in PMV Pharmaceuticals, Inc. ($PMVP) and Director in Prevail Therapeutics Inc. ($PRVL) and Director in Edgewise Therapeutics, Inc. ($EWTX).

Peter A Thompson in Silverback Therapeutics, Inc.

Trading Symbol: SBTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Peter A Thompson: Director
Holdings: 507,423 shares
Latest Transaction: Dec 08 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Peter A Thompson in Silverback Therapeutics, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ADAP, ALPN, CRVS, DBTX, EWTX, PMVP, PRVL, RPBIF, SRRA, SBTX, THOR, TRBN

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Option Exercise	C	0.00	3,918,279	0	0
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Option Exercise	C	0.00	9,259,259	0	0
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Option Exercise	C	0.00	3,918,279	0	0
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Option Exercise	C	0.00	12,857,142	0	0
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Option Exercise	C	0.00	9,259,259	0	0
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	P	21.00	952,377	19,999,917	952,377	0 to 952.4 K
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Option Exercise	C	0.00	12,857,142	0	0
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	C	0.00	1,055,287	0	7,519,188	6.5 M to 7.5 M (+16.33 %)
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	P	21.00	952,377	19,999,917	952,377	0 to 952.4 K
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	C	0.00	2,493,741	0	6,463,901	4 M to 6.5 M (+62.81 %)
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	C	0.00	1,055,287	0	7,519,188	6.5 M to 7.5 M (+16.33 %)
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	C	0.00	3,462,737	0	3,970,160	507.4 K to 4 M (+682.42 %)
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	C	0.00	2,493,741	0	6,463,901	4 M to 6.5 M (+62.81 %)
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	P	21.00	238,100	5,000,100	507,423	269.3 K to 507.4 K (+88.41 %)
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	C	0.00	3,462,737	0	3,970,160	507.4 K to 4 M (+682.42 %)
Dec 08 2020	SBTX	Silverback Therape ...	Thompson Peter A.	Director	Buy	P	21.00	238,100	5,000,100	507,423	269.3 K to 507.4 K (+88.41 %)

Page: 1